Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC] - N0000194088

Pharmacologic Code	N0000194088
Pharmacologic Name	Human Immunodeficiency Virus 1 Capsid Inhibitor
Pharmacologic Uses	human immunodeficiency virus type 1 (HIV-1) capsid inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	61958-3001	Sunlenca	Non-Proprietary Name: Lenacapavir Sodium	Tablet, Film Coated	Oral	Gilead Sciences, Inc.	ACTIVE
	61958-3401	Yeztugo	Non-Proprietary Name: Lenacapavir Sodium	Tablet, Film Coated	Oral	Gilead Sciences, Inc.	ACTIVE